Fundraising Fox

Bakx Therapeutics

Bearsville, US · Founded 2020 · Delaware corporation

Biotech

Founders & leadership

YS
Yibing ShanNamed on SEC filing
PL
Phillippe Lopes-FernandesNamed on SEC filing
EG
Ervis GavathiotisNamed on SEC filing
JE
Jessie EnglishNamed on SEC filing
SK
Sree KantNamed on SEC filing
LW
Loren WalenskyNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$20.3M disclosed across 1 round · 2021

▶$20.3MraisedSep 2021 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yibing ShanDirector
  • Phillippe Lopes-FernandesDirector
  • Ervis GavathiotisExecutive Officer, Promoter
  • Jessie EnglishExecutive Officer, Promoter
  • Sree KantExecutive Officer, Director, Promoter
  • Frances ToneguzzoPromoter
  • Loren WalenskyExecutive Officer, Promoter
Offering amount
$34.3M
Amount sold
$20.3M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Bakx Therapeutics raised?
Bakx Therapeutics has disclosed $20.3M raised across 1 round.
Where is Bakx Therapeutics headquartered?
Bakx Therapeutics is headquartered in Bearsville, US.